| Serial Number | 97263760 |
| Word Mark | CELLJUVANT STUDY CELL-BASED ADJUVANT TECHNOLOGYHNOLOGY |
| Filing Date | Friday, February 11, 2022 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Wednesday, May 22, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, April 4, 2023 |
| Description of Mark | The mark consists of of the wording "CELLJUVANT STUDY" above the wording "CELL-BASED ADJUVANT TECHNOLOGY". Above the "J" in "CELLJUVANT" is a design of a circle with an arrow-like shape through the circle. The tip of the arrow is a design of a rocket ship. The "CELL" element of "CELLJUVANT" is in the color purple. The "JUVANT" element of "CELLJUVANT" and the word "STUDY" are in the color red. The rest of the wording in the mark is in the color gray. The circle element of the design is in the colors red and gray, and the arrow-like element of the design is red and purple with the rocket ship element being in the color purple. |
| Indication of Colors claimed | The color(s) red, purple, and gray is/are claimed as a feature of the mark. |
| Goods and Services | Medical information; pharmaceutical information, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical information services in the field of pharmaceuticals for preventing and treating viruses and respiratory disorders, including vaccines and pharmaceutical therapeutics |
| NOT AVAILABLE | "STUDY CELL-BASED ADJUVANT TECHNOLOGY" |
| Goods and Services | Scientific research in the nature of conducting clinical trials for pharmaceutical preparations; scientific research in the nature of conducting clinical trials for flu vaccines; providing clinical trial research information about the results of clinical trials for flu vaccines; providing medical research and scientific research information in the field of flu vaccines and flu vaccine clinical trials; pharmaceutical research and development |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 16, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 16, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Seqirus Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Holly Springs, NC 27540 |
| Party Name | Seqirus Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Holly Springs, NC 27540 |
| Event Date | Event Description |
| Tuesday, February 15, 2022 | NEW APPLICATION ENTERED |
| Wednesday, February 16, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, February 17, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, May 23, 2022 | ASSIGNED TO EXAMINER |
| Friday, May 27, 2022 | NON-FINAL ACTION E-MAILED |
| Friday, May 27, 2022 | NON-FINAL ACTION WRITTEN |
| Friday, May 27, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, November 23, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, November 23, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 23, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, January 20, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, January 20, 2023 | NON-FINAL ACTION E-MAILED |
| Friday, January 20, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, February 13, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, February 13, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, February 14, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, February 24, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 15, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 4, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 4, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 30, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, November 30, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, November 30, 2023 | SOU EXTENSION 1 FILED |
| Thursday, November 30, 2023 | SOU EXTENSION 1 GRANTED |
| Friday, December 1, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, May 22, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, May 22, 2024 | SOU EXTENSION 2 FILED |
| Wednesday, May 22, 2024 | SOU EXTENSION 2 GRANTED |
| Thursday, May 23, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |